176 related articles for article (PubMed ID: 11029771)
1. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
Satoh F; Umemura S; Osamura RY
Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
[TBL] [Abstract][Full Text] [Related]
2. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
[TBL] [Abstract][Full Text] [Related]
3. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
[TBL] [Abstract][Full Text] [Related]
4. [Infiltrating lobular carcinoma of the breast with histiocytoid features: three cases].
Augros M; Buénerd A; Devouassoux-Shisheboran M; Berger G
Ann Pathol; 2004 Jun; 24(3):259-63; quiz 227. PubMed ID: 15480261
[TBL] [Abstract][Full Text] [Related]
5. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
[TBL] [Abstract][Full Text] [Related]
6. Gross cystic disease fluid protein-15 in salivary gland tumors.
Swanson PE; Pettinato G; Lillemoe TJ; Wick MR
Arch Pathol Lab Med; 1991 Feb; 115(2):158-63. PubMed ID: 1992983
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
Selim AA; El-Ayat G; Wells CA
Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
[TBL] [Abstract][Full Text] [Related]
8. Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.
Langel DJ; Yeatts RP; White WL
Am J Dermatopathol; 2001 Oct; 23(5):444-9. PubMed ID: 11801778
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
Ansai S; Koseki S; Hozumi Y; Kondo S
Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
[TBL] [Abstract][Full Text] [Related]
10. Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women.
Petrakis NL; Lowenstein JM; Wiencke JK; Lee MM; Wrensch MR; King EB; Hilton JF; Miike R
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):573-9. PubMed ID: 8268776
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast.
Gupta D; Croitoru CM; Ayala AG; Sahin AA; Middleton LP
Ann Diagn Pathol; 2002 Jun; 6(3):141-7. PubMed ID: 12089723
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study with antibody to glycoprotein GCDFP-15 for metastatic lung cancer from breast cancer.
Nonami Y; Hisa S; Yamamoto A; Sasaguri S; Kiyoku H; Kurumaya H
J Cardiovasc Surg (Torino); 2001 Aug; 42(4):561-4. PubMed ID: 11455297
[TBL] [Abstract][Full Text] [Related]
13. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
Raju U; Ma CK; Shaw A
Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
Mazoujian G; Pinkus GS; Davis S; Haagensen DE
Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
Wallace ML; Smoller BR
Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
[TBL] [Abstract][Full Text] [Related]
17. Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies.
Shimizu S; Kitamura H; Ito T; Nakamura T; Fujisawa J; Matsukawa H
Pathol Int; 1998 Jul; 48(7):549-56. PubMed ID: 9701019
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
Mazoujian G
Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
[TBL] [Abstract][Full Text] [Related]
19. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors.
Mazoujian G; Bodian C; Haagensen DE; Haagensen CD
Cancer; 1989 Jun; 63(11):2156-61. PubMed ID: 2655863
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein.
Ormsby AH; Snow JL; Su WP; Goellner JR
J Am Acad Dermatol; 1995 May; 32(5 Pt 1):711-6. PubMed ID: 7722013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
